SOUTHPOINT CAPITAL ADVISORS LP sold 26.7% of their position (1M shares) of FENNEC PHARMACEUTICALS INC. on the open market
Open‑market sale worth $7.50M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001012975-25-000985
10% Owner
Since May 2020
-1M
Net shares
Net seller
$7.50M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−1M
Price / share
$7.50
Trade value
$7.50M
% of position
26.7%
12/24/2025
3.74M→2.74M
Total
Net shares
−1M
Net value
-$7.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/24/2025 | S · Sale | −1M | $7.50 | $7.50M | 26.7% | 3.74M | 2.74M |
| Total | −1M | -$7.50M | ||||||
Derivative Transactions0
No derivative transactions reported